Skip to search formSkip to main contentSkip to account menu

4-bromobenzoyl-methyladamantylamine

Known as: 1-N-(para-bromobenzoyl)methyladamantylamine, BBMAA, Ethanone, 1-(4-bromophenyl)-2-(tricyclo(3.3.1.13,7)dec-1-ylamino)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Amantadine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Antagonism between adenosine and bromobenzoyl-methyladamantylamine, a K+-channel blocker, in atrial myocardium of guinea pig.
1984
1984
Comparative studies on the positive inotropic effect of isoproterenol and bromobenzoyl-methyladamantylamine in guinea pig ventricular myocardium.
The effects of bromobenzoyl-methyladamantylamine (BMA) on the transmembrane potentials, contractile force, and 42K efflux were… 
1984
1984
Ventricular automaticity induced by bromobenzoyl-methyladamantylamine (BMA) in different membrane potential ranges in guinea pig heart.
The electrophysiological effects of bromobenzoyl - methyladamantylamine ( BMA ) were investigated in isolated electrically driven… 
1982
1982
Inhibition of myocardial K+ channels by bromobenzoyl-methyladamantylamine, an adamantane derivative.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)